
The Bruton tyrosine kinase inhibitor showed a statistically-significant and clinically-meaningful improvement in progression-free survival in patients with previously-treated CLL.

The Bruton tyrosine kinase inhibitor showed a statistically-significant and clinically-meaningful improvement in progression-free survival in patients with previously-treated CLL.

At 42,000 US deaths a year, the push to call metastatic breast cancer "chronic" is premature.

A generous donor will match every donation up to $100,000 to the Tyler Trent Fund.

Funds raised to support cancer research in Virginia, nationwide.

Vision Boards are both therapeutic and fun for cancer survivors and everyone else!

The FDA approved Kadcyla for adjuvant treatment of patients with HER2-positive early breast cancer who have residual invasive disease after neoadjuvant taxane and Herceptin-based treatment.

From an FDA decision to keep textured breast implants on the market to TV personalities and politicians, here’s what’s making headlines in the cancer space this week.

Lack of awareness and knowledge of early-onset colorectal cancer is a problem, but early messaging can help combat the issue.

Surveillance guidelines for hereditary colorectal cancer may be more effective in preventing the disease compared with those intended for individuals with a family history.

The FDA has approved a supplemental new drug application for Tibsovo as a single agent for the first-line treatment of adult patients with IDH1-mutant acute myeloid leukemia who are 75 years and older or are ineligible to receive intensive chemotherapy.

Walgreens expands health and beauty support program for patients with cancer.

There are currently more than 700 new therapies in development for people with cancer, representing a trend that is being driven by increased innovation.

More and more patients are being offered palliative, or supportive, care, and this is a welcomed trend.

Here are the top 5 CURE stories for April 2019.

Researchers examined the prevalence of chronic opioid use among survivors of breast, colorectal and lung cancer.







Only half of patients reported their blood cancer was detected while visiting a doctor after experiencing symptoms versus detection during a routine medical test or exam or while under the care of a doctor for another health condition.

Since being diagnosed with cancer, I can't walk into a grocery story without hearing B.B. King sing "The Thrill is Gone." My relationship with food changed, and I often wonder if we'll ever be able to fall in love again.

Risk for disease progression among patients with chronic lymphocytic leukemia over time differed between those with mutated or unmutated disease, showing that gene somatic hypermutation plays a role throughout the disease course.

I didn't see how alone I was with cancer until I found purpose and friendships with advocacy.

The FDA has granted a priority review designation to a new drug application (NDA) for darolutamide for use as a treatment for patients with nonmetastatic castration-resistant prostate cancer.

With patient resistance to single-agent immunotherapies in the treatment of advanced renal cell carcinoma, new combination therapies are needed in the frontline setting.

Use of two medicated mouthwashes reduced pain from oral mucositis during the first four hours after administration; however, the results were not deemed clinically different when compared with placebo.

I'm often asked how things are going with my male breast cancer diagnosis. What's the right answer?